Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: The EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial
BMC Musculoskeletal Disorders - United Kingdom
doi 10.1186/s12891-017-1585-2
Full Text
Open PDFAbstract
Available in full text
Date
May 26, 2017
Authors
Publisher
Springer Science and Business Media LLC